Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Net Margin: 2009-2025

Historic Net Margin for Myriad Genetics (MYGN) over the last 16 years, with Sep 2025 value amounting to -13.32%.

  • Myriad Genetics' Net Margin fell 296.00% to -13.32% in Q3 2025 from the same period last year, while for Sep 2025 it was -48.53%, marking a year-over-year decrease of 3444.00%. This contributed to the annual value of -15.20% for FY2024, which is 1976.00% up from last year.
  • As of Q3 2025, Myriad Genetics' Net Margin stood at -13.32%, which was up 91.41% from -155.09% recorded in Q2 2025.
  • Over the past 5 years, Myriad Genetics' Net Margin peaked at 14.70% during Q3 2021, and registered a low of -155.09% during Q2 2025.
  • Over the past 3 years, Myriad Genetics' median Net Margin value was -17.35% (recorded in 2024), while the average stood at -33.68%.
  • Per our database at Business Quant, Myriad Genetics' Net Margin skyrocketed by 5,707bps in 2021 and then tumbled by 13,774bps in 2025.
  • Quarterly analysis of 5 years shows Myriad Genetics' Net Margin stood at -4.73% in 2021, then plummeted by 1,906bps to -23.79% in 2022, then soared by 792bps to -15.87% in 2023, then tumbled by 431bps to -20.18% in 2024, then slumped by 296bps to -13.32% in 2025.
  • Its Net Margin stands at -13.32% for Q3 2025, versus -155.09% for Q2 2025 and -0.05% for Q1 2025.